Metraipolis › archive › dc_c2ce2f0bd66f
Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP) — Europe PMC PMID:41472501
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41472501
- DOI
- 10.1111/1346-8138.70122
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T07:47:56.190Z
- SHA-256 of the archived text
0a7838122fa52a44c8457b1170a9cb165bfe220d1a17f5f86bf81abc30298c03- Stable URL of this page
https://metraipolis.com/documento/dc_c2ce2f0bd66f
How to cite
Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP) — Europe PMC PMID:41472501 — Europe PMC (en), https://europepmc.org/article/MED/41472501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2ce2f0bd66f (Metraipolis archive dc_c2ce2f0bd66f, sha256 0a7838122fa52a44c8457b1170a9cb165bfe220d1a17f5f86bf81abc30298c03)
BibTeX
@misc{dcc2ce2f0bd66f,
title = {Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP) — Europe PMC PMID:41472501},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41472501},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2ce2f0bd66f; sha256 0a7838122fa52a44c8457b1170a9cb165bfe220d1a17f5f86bf81abc30298c03},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41472501. Agents can read the archived copy with the MCP tool read_document.